These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 148342)
1. The antibody response of institutionalized Down's syndrome patients to seven microbial antigens. Hawkes RA; Boughton CR; Schroeter DR Clin Exp Immunol; 1978 Feb; 31(2):298-304. PubMed ID: 148342 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis-B surface antigen and antibody: prevalence and persistence in institutionalized and noninstitutionalized persons. McMillan BC; Hanson RP; Golubjatnikov R; Sinha SK Public Health Rep; 1979 Jun; 94(3):262-7. PubMed ID: 156381 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus infection among mentally retarded patients in institutions, Okinawa, Japan. Hayashi J; Kashiwagi S; Noguchi A; Nakashima K; Ikematsu H; Kajiyama W; Nomura H Fukuoka Igaku Zasshi; 1989 Sep; 80(9):436-40. PubMed ID: 2807128 [TBL] [Abstract][Full Text] [Related]
4. [Response to recombinant DNA antihepatitis B vaccine in mentally retarded patients with Down's syndrome. A controlled study]. García Bengoechea M; Cortés A; Cabriada J; Albizu I; Dorronsoro M; Arriola JA; Arenas JI Med Clin (Barc); 1990 Apr; 94(14):528-30. PubMed ID: 2141377 [TBL] [Abstract][Full Text] [Related]
5. Antibody to hepatitis B antigen (Australia antigen) among residents of a Finnish institution for the mentally retarded. Tevaluoto-Aarnio M; Werner B; London WT Med Biol; 1975 Feb; 53(1):51-9. PubMed ID: 124806 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis A and B in non-institutionalized mentally retarded patients. Renner F; Andrle M; Horak W; Rett A Hepatogastroenterology; 1985 Aug; 32(4):175-7. PubMed ID: 2932380 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis B infection in institutionalized Down's syndrome inmates: a longitudinal study with five hepatitis B virus markers. Hawkes RA; Boughton CR; Schroeter DR; Decker RH; Overby LR Clin Exp Immunol; 1980 Jun; 40(3):478-86. PubMed ID: 6448112 [TBL] [Abstract][Full Text] [Related]
8. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen. Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis and Down's syndrome. Madden DL; Matthew EB; Dietzman DE; Purcell RH; Sever JL; Rostafinski M; Mata A Am J Ment Defic; 1976 Jan; 80(4):401-6. PubMed ID: 129005 [TBL] [Abstract][Full Text] [Related]
10. [Hepatitis B at an open institution for the mentally retarded. Immunogenic effect of a recombinant anti-hepatitis-B vaccine]. García O; Bruguera M; Mayor A; Sánchez-Tapias JM; Vall O; Rodés J Enferm Infecc Microbiol Clin; 1990 Mar; 8(3):148-52. PubMed ID: 2151250 [TBL] [Abstract][Full Text] [Related]
11. [Occurrence of hepatitis B and C among mentally retarded]. Lunding S; Hansen KS; Krogsgaard K; Rosdahl N; Smith E; Wantzin PS Ugeskr Laeger; 1999 Aug; 161(31):4393-6. PubMed ID: 10487103 [TBL] [Abstract][Full Text] [Related]
12. Normal immune response to hepatitis B vaccine in patients with Down's syndrome. A basis for immunization guidelines. Troisi CL; Heiberg DA; Hollinger FB JAMA; 1985 Dec; 254(22):3196-9. PubMed ID: 2933533 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B vaccination in Down's syndrome and other mentally retarded patients. Heijtink RA; De Jong P; Schalm SW; Masurel N Hepatology; 1984; 4(4):611-4. PubMed ID: 6235163 [TBL] [Abstract][Full Text] [Related]
14. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection. Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033 [TBL] [Abstract][Full Text] [Related]
15. Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse. Böcher WO; Galun E; Marcus H; Daudi N; Terkieltaub D; Shouval D; Löhr HF; Reisner Y Hepatology; 2000 Feb; 31(2):480-7. PubMed ID: 10655274 [TBL] [Abstract][Full Text] [Related]
16. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948 [TBL] [Abstract][Full Text] [Related]
17. Anti-idiotypic humoral and cellular responses to antibody to hepatitis B surface antigen in hepatitis B viral infections. Rath S; Bal V; Mohite BJ; Haridas V; Naik SR; Kamat SA; Zuckerman AJ; Kamat RS Clin Exp Immunol; 1988 Sep; 73(3):360-5. PubMed ID: 3264769 [TBL] [Abstract][Full Text] [Related]
18. The response of institutionalized Down's syndrome subjects to enterovirus infections. Hawkes RA; Philbrook SC; Boughton CR J Hyg (Lond); 1980 Jun; 84(3):433-41. PubMed ID: 6300224 [TBL] [Abstract][Full Text] [Related]
19. Immunological studies of patients with Down's syndrome. Measurements of autoantibodies and serum antibodies to dietary antigens in relation to zinc levels. Kanavin O; Scott H; Fausa O; Ek J; Gaarder PI; Brandtzaeg P Acta Med Scand; 1988; 224(5):473-7. PubMed ID: 2974234 [TBL] [Abstract][Full Text] [Related]
20. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen. Frazer IH; Jones B; Dimitrakakis M; Mackay IR Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]